High Cholesterol

New research in The FASEB Journal suggests that fenofibrate activates cannabinoid receptors and may become a viable treatment option for relieving pain, stimulating appetite,...

Researchers found that a widely used statin hindered the positive effects of exercise for obese and overweight adults.

Researchers examine whether an alternative approach to treating high blood cholesterol may provide an effective treatment option for patients who are unable or unwilling to take statins.

A new review suggests that so far, only modest evidence supports the use of most medications to raise levels of high-density lipoprotein (good cholesterol).

A pill containing plant substances called sterols can help lower cholesterol.

There is good evidence to show that stress can increase a person's heart rate, lower the immune system's ability to fight colds and increase certain inflammatory markers but can stress also raise a person's cholesterol? It appears so for some people.

Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels.

ACP: All people with type 2 diabetes mellitus and coronary artery disease, and all people with diabetes and any other risk for cardiovascular disease, should be taking cholesterol-lowering drugs called statins.

Among nearly 45,000 men who were followed up for more than two decades, those with the risk factors of smoking, hypertension, high cholesterol, and type 2 diabetes had an associated greater risk of developing PAD.

The results of a person's omega 3 levels is a better predictor of death risk than the serum cholesterol tests routinely given to patients by their doctors. Have you had your omega 3 level tested?

Scientist: chylomicrons gather on arterial walls and may be as dangerous or more dangerous than low-density lipoprotein (LDL) cholesterol in causing strokes and heart attacks.

Just in time for the holidays, McGill researchers have identified a new way to reduce fat and cholesterol levels in the body.

NCEP suggests that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.

Metabolic Syndrome X is the term used to describe a group of heart disease risk factors.

Finding gives one more piece in the puzzle about the role of cholesterol in Parkinson's disease.

What's bad for your ticker may be good for your bean, according to research from a team of scientists at Boston University.